When used with a matching bluetooth inhaler sensor, records usage of reliever inhaler by people living with asthma or chronic obstructive pulmonary disease (COPD). In 2015 the app obtained U.S. Food and Drug Administration 510(k) clearance to market its Propeller platform in association with medications using GlaxoSmithKline's Diskus®
dry powder inhaler (DPI) device for asthma and chronic obstructive pulmonary disease (COPD) and Boehringer Ingelheim's Respimat®
inhaler for chronic obstructive pulmonary disease (COPD).
“Using a special GPS-enabled device that attaches to an inhaler, Propeller Health (formerly called Asthmapolis) automatically records the time and location when asthma patients use their inhalers. This data is transmitted to the patient’s doctor, while collective data is available to asthma researchers and public-health agencies. It maps and tracks asthma symptoms, triggers, and the use of rescue and controller medications and other important events from any phone. You can also receive text message reminders when you forget to use controller medication, and review streamlined versions of your asthma map and charts on the phone.”
Carcinoid Cancer Foundation (CCF), USA
Tags: Health, Wellness & Care in the Community (HWCC)